MREO241220P3000
- 0.05
- 0.000.00%
Mereo BioPharma Newsroom
Crude Oil Down 1%; Webuy Global Shares Spike Higher
Mereo BioPharma Shares Rise After Jefferies Begins Coverage at Buy
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Mereo BioPharma Group Price Target Announced at $7.00/Share by Jefferies
Mereo BioPharma Group Analyst Ratings
Jefferies Initiates Mereo BioPharma(MREO.US) With Buy Rating, Announces Target Price $7
Mereo BioPharma Files to Sell 26.64M Ordinary Shares for Holders
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)
Mereo BioPharma: Strong Cash Position Amid Clinical Progress
BTIG Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $6
Mereo BioPharma | 8-K: Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Mereo BioPharma | 10-Q: Quarterly report
Needham Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $7
Mereo Biopharma Group: Anticipated Positive Developments and Strong Financial Position Justify Buy Rating
Mereo BioPharma Reports Q3 EPS (2c), Consensus (2c)
Mereo BioPharma Group 3Q Loss/Shr 2c >MREO
Press Release: Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading